BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20931764)

  • 1. QSAR, docking studies and pharmacophore identification of phenylmethyl phenoxy propyl amino propanoic acid derivatives as leukotriene A4 hydrolase inhibitors.
    Sonawane LV; Bari SB
    Yao Xue Xue Bao; 2010 May; 45(5):615-23. PubMed ID: 20931764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of potent leukotriene A(4) hydrolase inhibitors. Identification of 3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid.
    Penning TD; Russell MA; Chen BB; Chen HY; Liang CD; Mahoney MW; Malecha JW; Miyashiro JM; Yu SS; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
    J Med Chem; 2002 Aug; 45(16):3482-90. PubMed ID: 12139459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid Receptor-Bound/MM-GBSA-Per-residue Energy-Based Pharmacophore Modelling: Enhanced Approach for Identification of Selective LTA4H Inhibitors as Potential Anti-inflammatory Drugs.
    Appiah-Kubi P; Soliman M
    Cell Biochem Biophys; 2017 Mar; 75(1):35-48. PubMed ID: 27914004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of leukotriene A4 (LTA4) hydrolase as potential anti-inflammatory agents.
    Penning TD
    Curr Pharm Des; 2001 Feb; 7(3):163-79. PubMed ID: 11311111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular docking and pharmacophore filtering in the discovery of dual-inhibitors for human leukotriene A4 hydrolase and leukotriene C4 synthase.
    Thangapandian S; John S; Sakkiah S; Lee KW
    J Chem Inf Model; 2011 Jan; 51(1):33-44. PubMed ID: 21133343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore-based virtual screening and Bayesian model for the identification of potential human leukotriene A4 hydrolase inhibitors.
    Thangapandian S; John S; Sakkiah S; Lee KW
    Eur J Med Chem; 2011 May; 46(5):1593-603. PubMed ID: 21377770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of predictive quantitative structure-activity relationship model and its application in the discovery of human leukotriene A4 hydrolase inhibitors.
    Thangapandian S; John S; Son M; Arulalapperumal V; Lee KW
    Future Med Chem; 2013 Jan; 5(1):27-40. PubMed ID: 23256811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase II: in vivo studies.
    Kachur JF; Askonas LJ; Villani-Price D; Ghoreishi-Haack N; Won-Kim S; Liang CD; Russell MA; Smith WG
    J Pharmacol Exp Ther; 2002 Feb; 300(2):583-7. PubMed ID: 11805220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase I: in vitro studies.
    Askonas LJ; Kachur JF; Villani-Price D; Liang CD; Russell MA; Smith WG
    J Pharmacol Exp Ther; 2002 Feb; 300(2):577-82. PubMed ID: 11805219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the inhibition of leukotriene A4 hydrolase.
    Ollmann IR; Hogg JH; Muñoz B; Haeggström JZ; Samuelsson B; Wong CH
    Bioorg Med Chem; 1995 Jul; 3(7):969-95. PubMed ID: 7582974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Human Leukotriene A4 Hydrolase Inhibitors Using Structure-Based Pharmacophore Modeling and Molecular Docking.
    Audat SA; Al-Shar'i NA; Al-Oudat BA; Bryant-Friedrich A; Bedi MF; Zayed AL; Al-Balas QA
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32580506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification and QSAR models of leukotriene A4 hydrolase (LTA4H) inhibitors by machine learning methods.
    Qin R; Wang H; Yan A
    SAR QSAR Environ Res; 2021 May; 32(5):411-431. PubMed ID: 33896285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrrolidine and piperidine analogues of SC-57461A as potent, orally active inhibitors of leukotriene A(4) hydrolase.
    Penning TD; Chandrakumar NS; Desai BN; Djuric SW; Gasiecki AF; Liang CD; Miyashiro JM; Russell MA; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3383-6. PubMed ID: 12419366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermodynamic properties of leukotriene A
    Wittmann SK; Kalinowsky L; Kramer JS; Bloecher R; Knapp S; Steinhilber D; Pogoryelov D; Proschak E; Heering J
    Bioorg Med Chem; 2016 Nov; 24(21):5243-5248. PubMed ID: 27651294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of leukotriene A4 hydrolase in complex with captopril and two competitive tight-binding inhibitors.
    Thunnissen MM; Andersson B; Samuelsson B; Wong CH; Haeggström J
    FASEB J; 2002 Oct; 16(12):1648-50. PubMed ID: 12207002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico modeling of the molecular structure and binding of leukotriene A4 into leukotriene A4 hydrolase.
    Paz PB; Vega-Hissi EG; Estrada MR; Garro Martinez JC
    Chem Biol Drug Des; 2012 Dec; 80(6):902-8. PubMed ID: 22913921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual anti-inflammatory and selective inhibition mechanism of leukotriene A4 hydrolase/aminopeptidase: insights from comparative molecular dynamics and binding free energy analyses.
    Appiah-Kubi P; Soliman ME
    J Biomol Struct Dyn; 2016 Nov; 34(11):2418-33. PubMed ID: 26555301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent and selective inhibitors of leukotriene A4 hydrolase: effects on purified enzyme and human polymorphonuclear leukocytes.
    Wetterholm A; Haeggström JZ; Samuelsson B; Yuan W; Munoz B; Wong CH
    J Pharmacol Exp Ther; 1995 Oct; 275(1):31-7. PubMed ID: 7562564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophore based 3D-QSAR modeling, virtual screening and docking for identification of potential inhibitors of β-secretase.
    Palakurti R; Vadrevu R
    Comput Biol Chem; 2017 Jun; 68():107-117. PubMed ID: 28288354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dynamics simulation study and hybrid pharmacophore model development in human LTA4H inhibitor design.
    Thangapandian S; John S; Arooj M; Lee KW
    PLoS One; 2012; 7(4):e34593. PubMed ID: 22496831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.